U.S. Office REITs Stock News

NYSE:IFF
NYSE:IFFChemicals

International Flavors & Fragrances (IFF) Is Up 7.2% After Benchmark Highlights Planned Food Ingredients Divestiture

Earlier this week, Benchmark began covering International Flavors & Fragrances, highlighting the company’s plan to divest its Food Ingredients segment as a key step in reshaping the business mix. At the same time, substantial recent insider purchases and mixed assessments of financial strength have drawn attention to the balance of opportunity and risk in IFF’s repositioning efforts. We’ll now examine how Benchmark’s coverage initiation, centered on the planned Food Ingredients divestiture,...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Technologies (AMPX) Stock Valuation After Drone Battery Deal And Short Seller Scrutiny

Why Amprius Technologies Stock Is Back in Focus Amprius Technologies (AMPX) is drawing attention after announcing a collaboration to supply silicon anode lithium-ion batteries for Matternet’s M2 delivery drones, while also facing short seller allegations about its reported orders and disclosures. See our latest analysis for Amprius Technologies. Recent volatility has been sharp, with the share price falling 4.62% in the last session, 17.17% over the week and 12.73% over 90 days. At the same...
NYSE:WM
NYSE:WMCommercial Services

Waste Management (WM) Stock Valuation After Stericycle Deal And New COO Appointment

Event: Stericycle Deal and New COO Put Healthcare and Sustainability in Focus Waste Management (WM) has moved deeper into healthcare waste and sustainability by acquiring Stericycle and naming Tara Hemmer as chief operating officer. This combination sharpens attention on the stock’s evolving business mix and margin profile. See our latest analysis for Waste Management. WM’s recent news sits against a mixed share performance, with the stock falling 7.39% on a 90 day share price return and a 1...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

How Investors Are Reacting To HealthEquity (HQY) AI Automation Push Amid Cybersecurity Scrutiny

Earlier this month, HealthEquity reported strong fiscal 2027 first-quarter results, highlighting growth in Health Savings Accounts and assets under management, supported by high client retention and enterprise wins. The company also emphasized expanding AI-driven automation while continuing to address ongoing litigation and regulatory scrutiny tied to a prior cybersecurity incident, underscoring how operational efficiency and data protection are becoming central to its business model. We’ll...
NYSE:ONTO
NYSE:ONTOSemiconductor

If Global Tensions Reshape Energy Flows These Stocks Could Shine

Energy stocks are again in the spotlight as investors watch headlines about a possible U.S. Iran deal, G7 talks on wars and trade, and fresh debates on AI and global security. These stories are not just politics; they can influence oil supply routes, risk premiums, and sentiment toward large producers and refiners. For investors, that mix can create pockets of opportunity and pockets of risk. This article highlights 3 large energy stocks from our screener that look particularly exposed to...
NasdaqGS:SCSC
NasdaqGS:SCSCElectronic

ScanSource (SCSC) Stock Valuation Update After Recent Share Price Momentum

Recent performance snapshot With no single headline event driving trading, ScanSource (SCSC) has quietly drawn attention after its stock price closed at US$50.01, with returns of 0.9% over the past day and 7.1% over the past week. Over the past month and the past 3 months, the stock shows returns of 18.8% and 41.1%. Year to date and 1-year total returns stand at 28.0% and 23.7%, respectively, putting recent moves into clearer context for investors. See our latest analysis for...
NYSE:CCI
NYSE:CCISpecialized REITs

How Investors Are Reacting To Crown Castle (CCI) Fiber Exit And Debt-Focused Balance Sheet Reset

In May 2026, Crown Castle completed the sale of its fiber and small-cell businesses, generating about US$8.40 billion in proceeds, committing over US$7.00 billion to debt reduction, and authorizing a US$1.00 billion share repurchase program as it reset its balance sheet. This move leaves Crown Castle as a focused U.S. tower infrastructure company, with a simpler business model and management guiding to improved 2026 cash flow metrics and ongoing capital returns. Next, we’ll assess how Crown...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Will Earnings Beat And Dividend Hike Change Gaming and Leisure Properties' (GLPI) Income-Focused Narrative?

Earlier this week, Gaming and Leisure Properties reported first-quarter 2026 results that surpassed analyst expectations and raised its quarterly cash dividend to US$0.82 per share, underscoring the company’s current payout level to shareholders. On the same day, director E. Scott Urdang sold 3,000 shares as part of a year-long pattern of insider sales, while external analysts highlighted the REIT’s casino-focused portfolio and recurring rental income as key underpinnings of its cash flow...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Should Sonos’ (SONO) 2026 Product Wave Amid Solid Demand Require Action From Investors?

Earlier in June 2026, Sonos emphasized resilient demand conditions as stronger-than-expected May retail sales signaled healthy consumer spending despite inflation and elevated gas prices. The company’s plan to roll out multiple new products in the second half of fiscal 2026 stands out as a key lever to tap its large install base and potentially counter hardware and component cost pressures. We’ll now examine how Sonos’s planned second-half 2026 product launches could reshape the company’s...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Qorvo (QRVO) Stock After Mixed Returns Is The Current Valuation Still Attractive

If you are wondering whether Qorvo at around US$98.59 is offering fair value or an opportunity, it helps to compare how the stock is priced with what the business may be worth. The share price performance has been mixed, with returns of 0.3% over the last 7 days, 6.9% over the last 30 days, 14.3% year to date, 24.1% over 1 year, while returns over 3 and 5 years declined 3.9% and 43.4% respectively. Recent coverage has focused on how Qorvo fits into the broader semiconductor sector and what...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

GH Research (GHRS) Stock Valuation After Positive Phase 2a Mebufotenin Data In Postpartum Depression

GH Research (NasdaqGM:GHRS) put fresh clinical data in front of investors with full Phase 2a results for inhaled GH001 in postpartum depression, along with new oral presentations accepted for the CINP 2026 congress. See our latest analysis for GH Research. The stock has eased over the past month despite the latest clinical update, with a 30 day share price return of about 1% lower. However, momentum over longer periods remains strong, including a 90 day share price return of 39.77% and a 1...
NYSE:SXI
NYSE:SXIMachinery

The Bull Case For Standex International (SXI) Could Change Following Its Shift Toward Higher-Margin Engineering Solutions

In recent days, Standex International has been highlighted for its long-running earnings per share growth, accelerating revenue, and expanding demand for its electrical, sensor, and precision engineering solutions tied to automation, electrification, and grid modernization. An interesting angle is how Standex’s stepped-up R&D and layered new product launches are helping shift its mix toward higher-margin, more specialized offerings. With this backdrop of ongoing earnings growth and...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

DLocal (DLO) Stock Weighs Undervaluation Narrative Against Mixed Returns And P/E Premium

What is DLocal and why the stock is drawing attention now? DLocal (NasdaqGS:DLO) has been drawing fresh interest after recent share price moves, with investors weighing its role as a global payments processor in relation to its current valuation and mixed return profile over different periods. See our latest analysis for DLocal. The share price has moved to US$12.25 with a 7 day share price return of 9.0% and a 30 day share price return of 11.3%, yet the year to date share price return is...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

Spyre Therapeutics (SYRE) Stock Valuation After SKYWAY Phase 2 Enrollment And Upcoming SPY072 Data

Spyre Therapeutics (SYRE) stock is reacting to fresh clinical updates after the company completed enrollment in all sub studies of its SKYWAY Phase 2 trial of SPY072 in multiple rheumatic disease indications. See our latest analysis for Spyre Therapeutics. At a share price of $80.79, Spyre Therapeutics has seen strong momentum recently, with a 7 day share price return of 9.7%, a 90 day share price return of 83.3% and a year to date share price return of 164.2%. The 1 year total shareholder...
NYSE:DEI
NYSE:DEIOffice REITs

Douglas Emmett (DEI) Stock Valuation After Recent Rebound And Modest Undervaluation Estimate

Douglas Emmett (DEI) has drawn investor attention after recent trading, with the stock last closing at US$12.28. You may be considering how this real estate investment trust’s fundamentals compare with its recent performance. See our latest analysis for Douglas Emmett. Recent trading has come after a period where the stock’s 90 day share price return of 27.78% contrasts with a 1 year total shareholder return that is down 12.45%. This suggests improving short term momentum after a weaker...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Berkshire Hathaway (BRK.B) Stock Valuation Check After A Year Of Flat Performance

Recent performance context for Berkshire Hathaway stock Berkshire Hathaway (BRK.B) has seen relatively muted share price moves recently, with a gain of about 0.7% over the past day, a small rise over the past week, and low single digit shifts over the past month and past 3 months. See our latest analysis for Berkshire Hathaway. Zooming out, Berkshire Hathaway’s share price has softened slightly year to date, but the 3 year and 5 year total shareholder returns of 44.62% and 78.53% show a...
NYSE:ORI
NYSE:ORIInsurance

How Investors May Respond To Old Republic International (ORI) Margin Pressures And Rising Options Volatility

In recent weeks, Old Republic International has faced ongoing scrutiny as slower net premium growth, higher expenses, and weaker margins have weighed on earnings quality, even as the company continues buybacks and a higher regular dividend. At the same time, a jump in implied volatility on near-term call options suggests traders are bracing for a sharper move in the shares tied to these profitability pressures. Now, we'll examine how these concerns over rising expenses and margin pressure...
NYSE:KVYO
NYSE:KVYOSoftware

Three AI Trade Stocks Powering Hardware Growth And Hidden Upside

Artificial intelligence is no longer a niche story; it now sits at the centre of global trade, powering 43% of trade growth while still only 15% of overall volume. Trade in AI-related hardware grew over 20% in the first half of 2025, even as wider goods trade stayed closer to 4% growth and global export growth is expected to cool in 2026. For investors, that mix of strength and friction can reward companies with scale, quality and real AI exposure. This article looks at 3 stocks from our...
NYSE:CRCL
NYSE:CRCLSoftware

If Geopolitics Squeezes Oil Supply These Energy Giants Matter

Geopolitics is back in the spotlight, and energy markets are feeling it. With the U.S.-Iran peace deal under pressure, renewed tensions around the Strait of Hormuz are raising questions about supply security and price risk that can ripple through your portfolio. Instead of reacting to headlines alone, it can help to focus on large, financially solid oil and gas producers that sit at the center of this story. This article highlights 3 stocks from our Energy Sector screener that appear...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Stock Valuation After Analyst Upgrades On Early Zovegalisib Data

Recent analyst upgrades for Relay Therapeutics (RLAY) focus on early clinical data for its drug candidate zovegalisib. Initial results in PIK3CA-driven vascular anomalies, particularly in heavily treated patients, have drawn increased attention to the stock. See our latest analysis for Relay Therapeutics. The recent enthusiasm around zovegalisib comes on top of strong price momentum, with a 1-month share price return of 21.39%, a 3-month share price return of 46.20% and a year-to-date share...
NYSE:ATO
NYSE:ATOGas Utilities

Fatal Oak Cliff Explosion Lawsuit Adds Legal And Safety Scrutiny For Atmos Energy (ATO)

In early June 2026, Hamilton Wingo filed the first wrongful death lawsuit in Dallas County Court at Law against Atmos Energy and several other parties over a fatal gas explosion that destroyed The Clyde apartment complex in Oak Cliff, killing three residents including 81-year-old community activist Sylvia Collins. The filing raises material questions about Atmos Energy’s gas line safety practices and potential liability, particularly given reports that residents smelled gas for days before...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Trupanion (TRUP) Stock Valuation Check After Recent Momentum And Underperformance

Short term moves and longer term context for Trupanion Trupanion (TRUP) has caught investor attention after recent price strength, with the stock up about 7.5% over the past week and roughly 6% over the past month, contrasting with a decline of about 6.7% over the past 3 months. See our latest analysis for Trupanion. That recent pick up in momentum sits against a weaker backdrop, with the share price down 36.42% year to date and the 1 year total shareholder return declining 53.47% despite the...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

Are Insider Sales and Fund Buying Sending Mixed Signals About ICU Medical’s Competitive Edge (ICUI)?

In May 2026, ICU Medical’s Vice President and General Counsel, Virginia Ruth Sanzone, sold 2,447 shares, about 11.17% of her direct holdings, while the Smiths Medical integration neared completion with manufacturing consolidation largely finished and new pump lines in development. At the same time, Madison Small Cap Fund disclosed a new position in ICU Medical, highlighting the company’s infusion therapy focus, market share gains amid competitors’ quality issues, and a high-volume connected...
NYSE:SPIR
NYSE:SPIRProfessional Services

Why Spire Global (SPIR) Is Up 6.2% After New Missile Early-Warning Satellite Partnership Announcement

Earlier this month, Diehl Defence announced it had signed a Memorandum of Understanding with Spire Global at the ILA Berlin Airshow 2026 to explore collaboration on satellite-based intelligence and early warning against ballistic and hypersonic missiles, drawing on Spire’s RF detection and analytics capabilities. This collaboration framework, paired with Spire’s new Munich facility capable of producing up to 100 satellites per year, highlights how the company is positioning itself as a...